Illumina Announces Decision to Divest GRAIL
SAN DIEGO, Dec. 17, 2023 /PRNewswire/ — Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL.
The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission’s divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.
Related news for (ILMN)
- Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
- Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
- Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
- Illumina advances personalized cancer care with new pharma development partnerships
- Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025